Clinical Research Directory
Browse clinical research sites, groups, and studies.
Dose Ranging Study of ORKA-002 in Patients With Moderate-to-Severe Plaque Psoriasis
Sponsor: Oruka Therapeutics, Inc.
Summary
This is a multicenter, randomized, double-blinded, placebo-controlled, dose-range finding study to evaluate the efficacy and safety of ORKA-002 in adult participants with moderate-to-severe plaque psoriasis.
Official title: A Multicenter, Randomized, Double-Blinded, Placebo- Controlled, Dose-Range Finding Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of ORKA-002 in Participants With Moderate-to-Severe Plaque Psoriasis
Key Details
Gender
All
Age Range
18 Years - 79 Years
Study Type
INTERVENTIONAL
Enrollment
160
Start Date
2026-03-19
Completion Date
2029-04
Last Updated
2026-05-27
Healthy Volunteers
No
Conditions
Interventions
ORKA-002
ORKA-002 administered by subcutaneous (SC) injection
Placebo
Placebo administered by subcutaneous (SC) injection
Locations (31)
Oruka Therapeutics Investigative Site
Birmingham, Alabama, United States
Oruka Therapeutics Investigative Site
Fountain Valley, California, United States
Oruka Therapeutics Investigative Site
Los Angeles, California, United States
Oruka Therapeutics Investigative Site
San Diego, California, United States
Oruka Therapeutics Investigative Site
Santa Ana, California, United States
Oruka Therapeutics Investigative Site
Santa Monica, California, United States
Oruka Therapeutics Investigative Site
Cromwell, Connecticut, United States
Oruka Therapeutics Investigative Site
Coral Gables, Florida, United States
Oruka Therapeutics Investigative Site
Milford, Massachusetts, United States
Oruka Therapeutics Investigative Site
Ann Arbor, Michigan, United States
Oruka Therapeutics Investigative Site
Detroit, Michigan, United States
Oruka Therapeutics Investigative Site
Warren, Michigan, United States
Oruka Therapeutics Investigative Site
New Brighton, Minnesota, United States
Oruka Therapeutics Investigative Site
Omaha, Nebraska, United States
Oruka Therapeutics Investigative Site
New York, New York, United States
Oruka Therapeutics Investigative Site
Wilmington, North Carolina, United States
Oruka Therapeutics Investigative Site
Bexley, Ohio, United States
Oruka Therapeutics Investigative Site
Portland, Oregon, United States
Oruka Therapeutics Investigative Site
Warrenton, Oregon, United States
Oruka Therapeutics Investigative Site
Dallas, Texas, United States
Oruka Therapeutics Investigative Site
Dallas, Texas, United States
Oruka Therapeutics Investigative Site
Mill Creek, Washington, United States
Oruka Therapeutics Investigative Site
Edmonton, Alberta, Canada
Oruka Therapeutics Investigative Site
Surrey, British Columbia, Canada
Oruka Therapeutics Investigative Site
Barrie, Ontario, Canada
Oruka Therapeutics Investigative Site
London, Ontario, Canada
Oruka Therapeutics Investigative Site
North Bay, Ontario, Canada
Oruka Therapeutics Investigative Site
Peterborough, Ontario, Canada
Oruka Therapeutics Investigative Site
Toronto, Ontario, Canada
Oruka Therapeutics Investigative Site
Waterloo, Ontario, Canada
Oruka Therapeutics Investigative Site
Saskatoon, Saskatchewan, Canada